Clinical Trials Study
Copyright ©The Author(s) 2020.
World J Gastroenterol. Aug 14, 2020; 26(30): 4501-4522
Published online Aug 14, 2020. doi: 10.3748/wjg.v26.i30.4501
Figure 5
Figure 5 Typical case 1 (pathology No. liver 0372). A: Focal necrosis in hepatic lobules with inflammatory cell infiltration (G1); B: Perisinusoidal fibrosis and lobular fibrosis (S1); C: Hepatitis B virus surface antigen (+++) in one immunohistochemistry assay of liver; D: Hepatitis B virus core antigen (+) in one immunohistochemistry assay of liver; E: Hepatitis B virus surface antigen (-) in two immunohistochemistry assays of liver; F: Hepatitis B virus core antigen (-) in two immunohistochemistry assays of liver.

  • Citation: Xing YF, Wei CS, Zhou TR, Huang DP, Zhong WC, Chen B, Jin H, Hu XY, Yang ZY, He Q, Jiang KP, Jiang JM, Hu ZB, Deng X, Yang F, Li FY, Zhao G, Wang LC, Mi YQ, Gong ZJ, Guo P, Wu JH, Shi WQ, Yang HZ, Zhou DQ, Tong GD. Efficacy of a Chinese herbal formula on hepatitis B e antigen-positive chronic hepatitis B patients. World J Gastroenterol 2020; 26(30): 4501-4522
  • URL: https://www.wjgnet.com/1007-9327/full/v26/i30/4501.htm
  • DOI: https://dx.doi.org/10.3748/wjg.v26.i30.4501